# LLM call: summary

- Turn: 13
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 860
- Completion tokens: 383
- Total tokens: 1243
- Cost (USD): 0.000163

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1508: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Through 2028-2031 defensive posture was tested by spring sweep: malware via update channel locked portals in three countries, forced hospitals offline for weeks; by autumn H2 2031 pooled hub + EU-only node and joint cyber accession delivered containment — cleaner networks but degraded services, late payments, paper slips.

Washington chip/model controls stayed tight, gigafactory shells empty; no EU relief request.

Office AI hiring collapse froze entry posts in law, accounting, software, back-offices. Brussels top-up became first-job guarantee — subsidised posts in town halls, offline hospitals, firms on EU hosting; DG EMPL advances to arrears first. Uneven: clean cities hired, others traded data-centre continuity for quotas, blockades, merged protests. Criticised as posts not careers.

Spring 2032: foreign labs brought tumour-tuned oncology and rapid rare-disease therapies into clinical use via frontier models on non-EU compute with rationed access — procurement panic for health ministries. Guarantee held barely with training allowance and quota deals reopening one blockaded site; queues shortened only where clean. Brussels promised European delivery via pilot oncology/rare-disease centres in clean cities, joint procurement, EU hosting/node — but protocols/procurement outran delivery, clinicians still routed complex cases abroad. Voters saw cure headlines alongside waiting lists; trust rose slightly from floor, budgets for holding jobs and cures nearly exhausted.

CURRENT NARRATIVE:
### The plug is pulled
In early autumn, hospital IT staff found clinical personalization queries failing. The leading foreign model, on which oncology pilots and rare-disease pathways had quietly come to depend, stopped answering European clinical users. No reason, no appeal date. Usage meters went dark. Within days ministries confirmed what wards already knew: drafts for tumour-tuned protocols no longer arrived.

The timing was brutal. The same weeks brought a near-frontier openly released model, downloaded hundreds of thousands of times in days, and a contested biosecurity paper claiming a genome model could guide a non-expert toward a viable human-infecting design. One dependence snapped shut just as distributed capability spread beyond recall.

### Continuity on paper
Brussels ran the cutoff as a health continuity operation. The new shield re-routed queries to accredited European hosting and the EU-only node, funded offline protocols in pilot centres, and retasked first-job cohorts to triage, records and cold-chain work. Reporting of clinical misuse was made mandatory and hospitals were told to screen outsourced synthesis orders.

It held services from stopping, barely. Where networks were clean, waiting lists froze rather than collapsed. Elsewhere, clinicians reverted to paper slips and older regimens. The promised European cure delivery shrank to a handful of cases processed domestically; complex cases simply waited.

Mayors in arrears cities took funded posts for siting calm, but blockaded sites hardened. The guarantee, now finishing its top-up phase, paid cohorts late. Voters saw two lessons at once: foreign cures could be withdrawn, and what was loose could not be taken back. Trust, already on the floor, slipped further.

No finishing date moved: with budgets exhausted, the shield will take well into next year to matter.
```

## Raw response

```
Through 2028-2031 malware via update channel and pooled hub + EU-only node containment left cleaner but degraded networks; US chip/model controls stayed tight; office AI hiring collapse led to Brussels first-job guarantee with uneven hiring and protests. Spring 2032 foreign tumour-tuned oncology and rare-disease therapies via non-EU frontier models created procurement panic; EU pilot centres and joint procurement promised but delivery lagged, budgets near-exhausted.

Early autumn 2032 the leading foreign clinical model cut off European users without appeal, halting tumour-tuned drafts, coinciding with a widely downloaded open near-frontier model and a biosecurity paper on genome-model misuse. Brussels ran health continuity: re-routing to EU hosting/node, offline protocols, retasking first-job cohorts to triage/records, mandatory misuse reporting and synthesis screening. Services barely held — lists froze where clean, paper/older regimens elsewhere, domestic cures to handful of cases, complex cases waited. Blockades hardened, guarantee payments late, trust slipped further; with budgets exhausted the shield will take well into next year to matter.
```
